Influence of the microbiota on vaccine effectiveness

Trends in Immunology

Volumn 35, Issue 11, 2014, Pages 526-537

  Valdez, Yanet ^a   Brown, Eric M ^a,b   Finlay, B Brett ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Immune system; Malnutrition; Microbiota; Probiotics; Vaccines

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; CELL POPULATION; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; INTESTINE FLORA; MALNUTRITION; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROFLORA; NONHUMAN; NUTRITIONAL STATUS; REVIEW; SANITATION; VACCINE FAILURE; AGE; ANIMAL; BIODIVERSITY; IMMUNE SYSTEM; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; PHYSIOLOGY;

AGE FACTORS; ANIMALS; BIODIVERSITY; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNE SYSTEM; INTESTINES; MICROBIOTA; NUTRITIONAL STATUS; PREBIOTICS; PROBIOTICS; VACCINES;

EID: 84927695047     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.07.003     Document Type: Review

References (93)

1. Brown E.M., et al. The role of the immune system in governing host-microbe interactions in the intestine. Nat. Immunol. 2013, 14:660-667.
2. Strober W. Impact of the gut microbiome on mucosal inflammation. Trends Immunol. 2013, 34:423-430.
3. Hooper L.V., et al. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
4. Smith K., et al. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 2007, 19:59-69.
5. Bouskra D., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456:507-510.
6. Hansen C.H., et al. Patterns of early gut colonization shape future immune responses of the host. PLoS ONE 2012, 7:e34043.
7. Atarashi K., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
8. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12204-12209.
9. Chung H., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012, 149:1578-1593.
10. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
11. Atarashi K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500:232-236.
12. Kamada N., et al. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13:321-335.
13. Amendola A., et al. Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms. Mucosal Immunol. 2014, 7:391-404.
14. Rakoff-Nahoum S., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
15. Slack E., et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009, 325:617-620.
16. Couturier-Maillard A., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 2013, 123:700-711.
17. Macpherson A.J., et al. The habitat, double life, citizenship, and forgetfulness of IgA. Immunol. Rev. 2012, 245:132-146.
18. Suzuki K., et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1981-1986.
19. Ichinohe T., et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5354-5359.
20. Yatsunenko T., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
21. Palmer C., et al. Development of the human infant intestinal microbiota. PLoS Biol. 2007, 5:e177.
22. Penders J., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
23. Guaraldi F., Salvatori G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Front. Cell. Infect. Microbiol. 2012, 2:94.
24. Jost T., et al. New insights in gut microbiota establishment in healthy breast fed neonates. PLoS ONE 2012, 7:e44595.
25. Hallander H.O., et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 2002, 21:138-145.
26. Levine M.M. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol. 2010, 8:129.
27. Jiang V., et al. Performance of rotavirus vaccines in developed and developing countries. Hum. Vaccin. 2010, 6:532-542.
28. Goveia Michelle G., et al. RotaTeq: progress toward developing world access. J. Infect. Dis. 2010, 202:S87-S92.
29. Lopman B.A., et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS ONE 2012, 7:e41720.
30. Grassly N.C., et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J. Infect. Dis. 2009, 200:794-801.
31. Johnson R.A., et al. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin. Vaccine Immunol. 2012, 19:1712-1721.
32. Leung D.T., et al. Comparison of memory B Cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clin. Vaccine Immunol. 2011, 18:1317-1325.
33. Korpe P.S., Petri W.A. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol. Med. 2012, 18:328-336.
34. Campbell D.I., et al. Chronic T cell-mediated enteropathy in rural west african children: relationship with nutritional status and small bowel function. Pediatr. Res. 2003, 54:306-311.
35. Ghoshal U.C., et al. Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time. J. Gastroenterol. Hepatol. 2003, 18:540-547.
36. Humphrey J.H. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009, 374:1032-1035.
37. Reikie B.A., et al. Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life. PLoS ONE 2012, 7:e44763.
38. Smolen K.K., et al. Pattern recognition receptor-mediated cytokine response in infants across 4 continents. J. Allergy Clin. Immunol. 2014, 133:818-826.
39. Khan Y., Bhutta Z.A. Nutritional deficiencies in the developing world: current status and opportunities for intervention. Pediatr. Clin. North Am. 2010, 57:1409-1441.
40. Savy M., et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J. Nutr. 2009, 139:2154S-2218S.
41. Mora J.R., et al. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 2008, 8:685-698.
42. Ibs K.H., Rink L. Zinc-altered immune function. J. Nutr. 2003, 133:1452S-1456S.
43. Kaufman D.R., et al. Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunity. J. Immunol. 2011, 187:1877-1883.
44. Klebanoff C.A., et al. Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J. Exp. Med. 2013, 210:1961-1976.
45. + dendritic cells. Eur. J. Immunol. 2013, 43:1608-1616.
46. Mora J.R., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314:1157-1160.
47. Spencer S.P., et al. Adaptation of Innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 2014, 343:432-437.
48. Zhao N., et al. Gestational zinc deficiency impairs humoral and cellular immune responses to hepatitis B vaccination in offspring mice. PLoS ONE 2013, 8:e73461.
49. David L.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2013, 505:559-563.
50. Nemes E., et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics 2008, 121:e1570-e1576.
51. Smith M.I., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013, 339:548-554.
52. Hashimoto T., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012, 487:477-481.
53. Hardy H., et al. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 2013, 5:1869-1912.
54. Maidens C., et al. Modulation of vaccine response by concomitant probiotic administration. Br. J. Clin. Pharmacol. 2013, 75:663-670.
55. Licciardi P.V., Tang M.L. Vaccine adjuvant properties of probiotic bacteria. Discov. Med. 2011, 12:525-533.
56. MacDonald T.T., Bell I. Probiotics and the immune response to vaccines. Proc. Nutr. Soc. 2010, 69:442-446.
57. Davidson L.E., et al. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur. J. Clin. Nutr. 2011, 65:501-507.
58. de Vrese M., et al. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur. J. Nutr. 2005, 44:406-413.
59. Paineau D., et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol. Med. Microbiol. 2008, 53:107-113.
60. Rizzardini G., et al. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei, L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br. J. Nutr. 2012, 107:876-884.
61. Kukkonen K., et al. Effect of probiotics on vaccine antibody responses in infancy - a randomized placebo-controlled double-blind trial. Pediatr. Allergy Immunol. 2006, 17:416-421.
62. Matsuda F., et al. Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 2011, 29:1855-1858.
63. West N.P., Cripps A.W. Are vaccination models suitable to determine whether probiotics have beneficial health effects in the general population?. Hum. Vaccin. Immunother. 2013, 9:621-624.
64. Youngster I., et al. Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. Arch. Dis. Child. 2011, 96:345-349.
65. Licciardi P.V., et al. Maternal supplementation with LGG reduces vaccine-specific immune responses in infants at high-risk of developing allergic disease. Front. Immunol. 2013, 4:381.
66. Soh S.E., et al. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010, 28:2577-2579.
67. Chattha K.S., et al. Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model. J. Immunol. 2013, 191:2446-2456.
68. Wen K., et al. High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 2012, 30:1198-1207.
69. Bosch M., et al. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutr. Hosp. 2012, 27:504-509.
70. Benyacoub J., et al. Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice. J. Nutr. 2008, 138:123-129.
71. Vos A.P., et al. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response. Int. Immunopharmacol. 2010, 10:619-625.
72. Stam J., et al. A mixture of three prebiotics does not affect vaccine specific antibody responses in healthy term infants in the first year of life. Vaccine 2011, 29:7766-7772.
73. Duggan C., et al. Oligofructose-supplemented infant cereal: two randomized, blinded, community-based trials in Peruvian infants. Am. J. Clin. Nutr. 2003, 77:937-942.
74. Van Den Berg J.P., et al. Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial. PLoS ONE 2013, 8:e70904.
75. Van Hoffen E., et al. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009, 64:484-487.
76. Arslanoglu S., et al. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J. Nutr. 2007, 137:2420-2424.
77. Arslanoglu S., et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J. Biol. Regul. Homeost. Agents 2012, 26:49-59.
78. Arslanoglu S., et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 2008, 138:1091-1095.
79. Klein S.L., et al. The Xs and Y of immune responses to viral vaccines. Lancet Infect. Dis. 2010, 10:338-349.
80. Benn C.S., et al. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013, 34:431-439.
81. Markle J.G., Fish E.N. SeXX matters in immunity. Trends Immunol. 2014, 35:97-104.
82. Ferreira R.B., et al. Should the human microbiome be considered when developing vaccines?. PLoS Pathog. 2010, 6:e1001190.
83. Eloe-Fadrosh E.A., et al. Impact of oral typhoid vaccination on the human gut microbiota and correlations with S. Typhi-specific immunological responses. PLoS ONE 2013, 8:e62026.
84. Seekatz A.M., et al. Differential response of the cynomolgus macaque gut microbiota to Shigella infection. PLoS ONE 2013, 8:e64212.
85. Lupp C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2:204.
86. Ivanov I.I., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
87. Liu C.H., et al. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3951-3956.
88. Mazmanian S.K., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
89. Mazmanian S.K., et al. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
90. Round J.L., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
91. Wingender G., et al. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 2012, 143:418-428.
92. Fang H., et al. Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 2000, 29:47-52.
93. Akatsu H., et al. Lactobacillus in jelly enhances the effect of influenza vaccination in elderly individuals. J. Am. Geriatr. Soc. 2013, 61:1828-1830.